National Center for Tumor Diseases (NCT) Heidelberg
Guy Ungerechts serves as the Deputy Director of the Medical Oncology Department at the National Center for Tumor Diseases (NCT) Heidelberg since October 2017. Additionally, Guy holds the position of Head of the Clinical Cooperation Unit Virotherapy at the DKFZ German Cancer Research Center starting in June 2019. As the Founder, Chief Medical Officer, and Chief Scientific Officer at CanVirex since September 2017, Guy also contributes to academia as an Adjunct Professor at the University of Ottawa, affiliated with the Ottawa Hospital Research Institute since July 2017.
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.